# Safety & Efficacy of NV1020 in Colorectal Cancer Metastatic to the Liver

> **NCT00149396** · PHASE1,PHASE2 · COMPLETED · sponsor: **MediGene** · enrollment: 32 (actual)

## Conditions studied

- Colorectal Cancer
- Liver Neoplasms

## Interventions

- **DRUG:** NV1020

## Key facts

- **NCT ID:** NCT00149396
- **Lead sponsor:** MediGene
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** 2008-10
- **Final completion:** 2008-12
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2018-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00149396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00149396, "Safety & Efficacy of NV1020 in Colorectal Cancer Metastatic to the Liver". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00149396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*